What CJC-1295 is

CJC-1295 is a modified GHRH fragment designed to bind pituitary GHRH receptors and raise the amplitude of endogenous GH release in experimental systems. Two families appear in the literature: a DAC (drug affinity complex) form with a multi-day half-life, and a non-DAC form (often called Mod GRF 1-29) with a half-life measured in minutes, intended to preserve a pulsatile pattern.

Catalogues that only say “CJC-1295” without DAC/non-DAC are doing the reader a disservice. The two forms are not interchangeable in a protocol. 10KITSM’s blend is the short-acting pairing with Ipamorelin that laboratories order as a combined secretagogue reference — not a long-acting DAC monotherapy.

Mechanism in published models

GHRH-receptor agonism increases GH synthesis and release from the anterior pituitary. In combination studies, a GHRH analogue plus a ghrelin-mimetic (GHRP) produces a larger GH pulse than either ligand alone — the reason CJC-1295 is almost always listed next to Ipamorelin rather than sold as a story of its own.

A 2006 clinical paper on the DAC form reported sustained GH and IGF-1 elevation for days after a single dose. That paper describes DAC CJC-1295, not the blend on this site. Do not read our 5mg + 5mg vial as that long-acting product.

CJC-1295 is not approved in Australia for anti-ageing or performance use. It is WADA-prohibited. This profile is for researchers identifying which secretagogue they are actually looking at.

How 10KITSM supplies CJC-1295

There is no CJC-1295-only vial here. Five milligrams sit in one lyophilised blend with 5mg Ipamorelin. If you need DAC CJC-1295, a different mass, or a single analogue, this catalogue does not have it.

The blend is HPLC-tested to 99%+ and ships discreetly in Australia. Reference reconstitution notes are in the user guide; they restate published research schedules, not a prescription.

CJC-1295 + Ipamorelin blend (5mg + 5mg)

Frequently asked questions

Do you sell CJC-1295 on its own?

No. 10KITSM supplies 5mg of CJC-1295 inside the 10mg CJC-1295 + Ipamorelin blend. There is no standalone CJC-1295 vial, and no DAC SKU.

Is this CJC-1295 with DAC?

No. The blend is the short-acting GHRH analogue paired with Ipamorelin. It is not the long-acting DAC form described in the 2006 clinical paper.

Is CJC-1295 for human use?

No. It is a laboratory research material only — not for human or veterinary use.

Related

All products are sold strictly for laboratory and research use only. Not for human or veterinary use, not for ingestion, and not intended to diagnose, treat, cure, or prevent any disease. Dosing information is provided for reference to published research only.